LARP7 alleviates psoriasis symptoms in mice by regulating the SIRT1/NF-κB signaling pathway

Main Article Content

Na Li
Yulei Liu

Keywords

inflammatory cytokines, La ribonucleoprotein 7, oxidative stress, psoriasis, SIRT1/NF-κB, transcriptional -regulator (LARP7)

Abstract

Objective: To unravel the role of La ribonucleoprotein 7 (LARP7), a transcriptional regulator, in the progression of psoriasis and the underlying molecular mechanisms.


Methods: The psoriasis-like mice model was created by daily administering of imiquimod on shaved skin. The histological analysis and skin damage were evaluated in each group. The inflammation and oxidative stress response were assessed by enzyme-linked-immunosorbent serologic and immunoblot assays. The involvement of silent information regulator 1 (member of the Sirtuin family; SIRT1/nuclear factor kappa B (NF-κB) signaling pathway in LARP7-mediated psoriasis progression was also detected by immunoblot assay.


Results: LARP7 relieved psoriasis symptoms in the mice model. LARP7 inhibited the expression of inflammatory cytokines as well as chemokines in psoriasis-like skin tissues. Additionally, LARP7 suppressed oxidative stress in the psoriasis-like skin tissues of mice. LARP7 inhibited the activation of the SIRT1/NF-κB signaling pathway, and therefore affected the progression of psoriasis.


Conclusion: LARP7 relieved psoriasis symptoms in mice by regulating the SIRT1/NF-κB signaling pathway.

Abstract 79 | PDF Downloads 44 HTML Downloads 8 XML Downloads 2

References

1. Kapoor B, Gulati M, Rani P, Gupta R. Psoriasis: Interplay between dysbiosis and host immune system. Autoimmun Rev. 2022;21(11):103169. 10.1016/j.autrev.2022.103169

2. Li AH, Chen YQ, Chen YQ, Song Y, Li D. CCNB1 and CCNB2 involvement in the pathogenesis of psoriasis: A bioinformatics study. J Int Med Res. 2022;50(8):3000605221117138. 10.1177/03000605221117138

3. Bae SJ, Lee SH, Yun SJ, Kim K. Usefulness of the blood urea nitrogen-to-serum albumin ratio as a prognostic indicator of severity in acute ischemic stroke. Signa Vitae. 2021;17(4):163-70. 10.22514/sv.2021.028

4. Brozyna AA, Slominski RM, Nedoszytko B, Zmijewski MA, Slominski AT. Vitamin D signaling in psoriasis: Pathogenesis and therapy. Int J Mol Sci. 2022;23(15):8575. 10.3390/ijms23158575

5. Armstrong A, Xia Q, John AR, Patel V, Seigel L. Treatment patterns for targeted therapies, non-targeted therapies, and drug holidays in patients with psoriasis. Dermatol Ther. 2022;12(9):2087–2103. 10.1007/s13555-022-00775-1

6. Ruiz-Villaverde R, Rodriguez-Fernandez-Freire L, Armario-Hita JC, Perez-Gil A, Chinchay FV, Galan-Gutierrez M. Guselkumab as a switching strategy after anti-TNF alpha, anti-IL17, or anti-IL12/23 therapies in moderate-to-severe psoriasis. Dermatol Ther. 2022 Oct;35(10):e15760. 10.1111/dth.15760

7. Megna M, Marano L, Camela E, Potestio L, Fabbrocini G, Scalvenzi M, et al. A case of severe psoriatic arthritis with hands flexion contracture and palmar psoriasis successfully treated with guselkumab. Dermatol Ther. 2022;35(10):e15766. 10.1111/dth.15766.

8. Yan P, Li Z, Xiong J, Geng Z, Wei W, Zhang Y, et al. LARP7 ameliorates cellular senescence and aging by allosterically enhancing SIRT1 deacetylase activity. Cell Rep. 2021;37(8):110038. 10.1016/j.celrep.2021.110038

9. Sui X, Sui Y, Wang Y. LARP7 in papillary thyroid carcinoma induces NIS expression through suppression of the SHH signaling pathway. Mol Med Rep. 2018;17(6):7521–8. 10.3892/mmr.2018.8856

10. Mennie AK, Moser BA, Nakamura TM. LARP7-like protein Pof8 regulates telomerase assembly and poly(A)+TERRA expression in fission yeast. Nat Commun. 2018;9(1):586. 10.1038/s41467-018-02874-0

11. Imbert-Bouteille M, Mau Them FT, Thevenon J, Guignard T, Gatinois V, Riviere JB, et al. LARP7 variants and further delineation of the Alazami syndrome phenotypic spectrum among primordial dwarfisms: 2 Sisters. Eur J Med Genet. 2019;62(3):161–6. 10.1016/j.ejmg.2018.07.003

12. Tang L, Li T, Zhang B, Zhang Z, Sun X, Zhu Y, et al. Punicalagin alleviates psoriasis by inhibiting NF-kappa B-mediated IL-1 beta transcription and caspase-1-regulated IL-1 beta secretion. Front Pharmacol. 2022;13:817526. 10.3389/fphar.2022.817526

13. Yang K, Oak ASW, Elewski BE. Use of IL-23 inhibitors for the treatment of plaque psoriasis and psoriatic arthritis: A comprehensive review. Am J Clin Dermatol. 2021;22(2):173–92. 10.1007/s40257-020-00578-0

14. Zhang M, Han M, Li J, Tao K, Yang X, Zheng H, et al. hsa_circ_0056856 in the serum serves as a potential novel biomarker for disease activity in psoriasis. Chin Med J. 2022;135(14):1759-1761. 10.1097/CM9.0000000000002166.

15. Shu X, Chen XX, Kang XD, Ran M, Wang YL, Zhao ZK, et al. Identification of potential key molecules and signaling pathways for psoriasis based on weighted gene co-expression network analysis. World J Clin Cases. 2022;10(18):5965–83. 10.12998/wjcc.v10.i18.5965.

16. Ruiz-Villaverde R, Velasco-Amador JP, Prados-Carmona A, Ruiz-Carrascosa JC. Switching from reference adalimumab to biosimilar. Assessment of clinical outcomes in psoriasis. Int J Dermatol. 2022. doi: 10.1111/ijd.16399. Online ahead of print.

17. Nassar AA, Bakr NM, Elyousefi EHI, Elkholy BM, Fawzy MM. Serum immunoglobulin E and interleukin-17 levels in patients with chronic plaque psoriasis: A case-control study. J Cosmet Dermatol. 2022. 10.1111/jocd.15299. Online ahead of print.

18. Liu Y, Wang H, Cook C, Taylor MA, North JP, Hailer A, et al. Defining patient-level molecular heterogeneity in psoriasis vulgaris based on single-cell transcriptomics. Front Immunol. 2022;13:842651. 10.3389/fimmu.2022.842651.

19. Li G, Gu Y, Zou Q, Wang Y, Xiao Y, Xia D, et al. Efficacy, safety, and pharmacoeconomic analysis of adalimumab and secukinumab for moderate-to-severe plaque psoriasis: A single--center, real-world study. Dermatol Ther. 2022;12(9):2105–15. 10.1007/s13555-022-00787-x.

20. Von Dwingelo J, Chung IYW, Price CT, Li L, Jones S, Cygler M, et al. Interaction of the ankyrin H core effector of legionella with the host LARP7 component of the 7SK snRNP complex. mBio. 2019;10(4):e01942–19. 10.1128/mBio.01942-19..

21. Fan X, Yan K, Meng Q, Sun R, Yang X, Yuan D, et al. Abnormal expression of SIRTs in psoriasis: Decreased expression of SIRT 1–5 and increased expression of SIRT 6 and 7. Int J Mol Med. 2019;44(1):157–71. 10.3892/ijmm.2019.4173

22. Garcia-Peterson LM, Li X. Trending topics of SIRT1 in tumorigenicity. Biochim Biophys Acta Gen Subj. 2021;1865(9):129952. 10.1016/j.bbagen.2021.129952

23. Krueger BJ, Jeronimo C, Roy BB, Bouchard A, Barrandon C, Byers SA, et al. LARP7 is a stable component of the 7SK snRNP while P-TEFb, HEXIM1 and hnRNP A1 are reversibly associated. Nucleic Acids Res. 2008;36(7):2219–29. 10.1093/nar/gkn061